Press "Enter" to skip to content

Covid-19 Vaccines Effectiveness in Question by FDA

The US Food and Drug Administration will meet on Friday to evaluate Covid-19 enhancers, after weeks of debate. One expert, however, stated that the science behind the vaccine’s success will not be debated. According to CNN Medical Analyst Dr. Leana Wen, there is universal consensus that the immunizations are primarily intended to prevent hospitalizations and fatalities, which statistics shows they accomplish successfully. Officials and health professionals are debating this problem presently, as the average number of new cases each day has increased dramatically in the last two months.

Many specialists, including President Joe Biden, believe that a third dose is warranted. Three studies released on Wednesday back up the idea that people may require a booster dose of Pfizer’s Covid-19 vaccine in the future, and that such boosters are safe. The studies are part of a batch of data that the FDA’s vaccine advisers will evaluate as it analyzes Pfizer’s request for approval of a third, booster dosage for most people six months after they receive their initial two vaccination doses.

However, there is currently no consensus. In the Lancet on Monday, a panel of worldwide vaccine experts, including representatives from the FDA and the World Health Organization, said that current data does not support the use of vaccines. There’s also concern that focusing on boosters may divert attention away from the aim of getting more people to get their first doses.

Only about 54% of the US population is fully vaccinated, despite the fact that doctors agree that vaccination is the best way to defend against the virus. Dr. Francis Collins, director of the National Institutes of Health, said Wednesday that there is no clear answer yet on whether vaccination boosters are essential, but there is “a mountain” of evidence for specialists to evaluate before reaching a judgment.

Comments are closed.